Cargando…

Pioglitazone reduces cardiovascular events and dementia but increases bone fracture in elderly patients with type 2 diabetes mellitus: a national cohort study

The prevalence of type 2 diabetes (T2DM) in elderly people has expanded rapidly. Considering cognitive impairment and being prone to hypoglycemia of the elder, the pros and cons of oral hypoglycemic agents (OHA) should be reassessed in this population. Pioglitazone might be appropriate for elderly D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Chieh-Li, Wu, Chao-Yi, Tsai, Chung-Ying, Lee, Cheng-Chia, Li, Yi-Jung, Peng, Wei-Sheng, Liu, Jia-Rou, Liu, Yuan-Chang, Jenq, Chang-Chyi, Yang, Huang-Yu, See, Lai-Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120904/ https://www.ncbi.nlm.nih.gov/pubmed/37036483 http://dx.doi.org/10.18632/aging.204643

Ejemplares similares

Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016
por: Lin, Min-Hao, et al.
Publicado: (2020)

Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study
por: Yen, Chieh-Li, et al.
Publicado: (2020)

Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time‐series analysis
por: Fang, Yao‐Fan, et al.
Publicado: (2022)

Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan
por: Huang, Wen-Kuan, et al.
Publicado: (2020)

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study
por: Fan, Yen-Chun, et al.
Publicado: (2017)

Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats
por: Liu, Szu-Yu, et al.
Publicado: (2021)

Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
por: Tseng, Chin-Hsiao
Publicado: (2018)

Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study
por: Lee, Kuang-Tso, et al.
Publicado: (2017)

Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients
por: Chang, Chih-Hsiang, et al.
Publicado: (2015)

Developmental Trajectories and Predictors of Incident Dementia among Elderly Taiwanese People: A 14-Year Longitudinal Study
por: Fan, Yen-Chun, et al.
Publicado: (2023)

Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies
por: Chen, Dong-Yi, et al.
Publicado: (2022)

Delayed Fever and Acute Kidney Injury in Patients with Urinary Tract Infection
por: Lu, Kun-Lin, et al.
Publicado: (2020)

Sodium‐glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
por: Liao, Hung‐Wei, et al.
Publicado: (2018)

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan
por: Chang, Chia-Yu, et al.
Publicado: (2017)

Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study
por: Tung, Ying-Chang, et al.
Publicado: (2021)

The efficacy of pioglitazone for renal protection in diabetic kidney disease
por: Ho, Chao-Chung, et al.
Publicado: (2022)

The Effects of e-interventions on the Medical Outcomes of Hemodialysis Patients: A Retrospective Matched Patient Cohort Study
por: Jenq, Chang-Chyi, et al.
Publicado: (2017)

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor
por: Lee, Hsin-Fu, et al.
Publicado: (2020)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
por: Tafuri, Kimberly Sue, et al.
Publicado: (2013)

Arrhythmia and other modifiable risk factors in incident dementia and MCI among elderly individuals with low educational levels in Taiwan
por: Huang, Yen-Chang, et al.
Publicado: (2022)

Association between air pollutants and dementia risk in the elderly
por: Wu, Yun-Chun, et al.
Publicado: (2015)

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Tung, Ying-Chang, et al.
Publicado: (2020)

Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
por: Park, Jong Suk, et al.
Publicado: (2011)

The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
por: Mori, Hiroko, et al.
Publicado: (2017)

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
por: Chang, Shang-Hung, et al.
Publicado: (2014)

A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan
por: Wu, Lung-Sheng, et al.
Publicado: (2016)

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
por: Yang, Shao-ling, et al.
Publicado: (2018)

Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
por: Tsai, Hui-Ju, et al.
Publicado: (2021)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly
por: Wu, Chen-Yi, et al.
Publicado: (2014)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
por: Jonker, Jacqueline T, et al.
Publicado: (2009)

Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use With Mortality Among Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease
por: Chen, Jia-Jin, et al.
Publicado: (2022)

The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients
por: Tsai, Tsung-Ting, et al.
Publicado: (2017)

Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
por: Wang, Yao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d199jgfm5mjs6m7fq7kbungje4